Asia FX cautious amid US govt shutdown; yen tumbles after Takaichi’s LDP win
STAMFORD, CT - Philip Morris International Inc. (NYSE:PM), a $251.79 billion tobacco giant with an impressive 66.44% gross profit margin, announced Friday that its Board of Directors has approved an 8.9% increase to the company’s regular quarterly dividend, raising it to $1.47 per share from the previous $1.35 per share.
The new dividend will be payable on October 20, 2025, to shareholders of record as of October 3, 2025, which is also the ex-dividend date. The increase brings PMI’s annualized dividend rate to $5.88 per share, offering investors a current yield of 3.34%. According to InvestingPro, the company has maintained dividend payments for 18 consecutive years.
This marks the company’s consecutive annual dividend increase since becoming a public company in 2008, representing a total increase of 219.6% over that period, or a compound annual growth rate of 7.1%.
PMI, a leading international consumer goods company, reported that its smoke-free products were available for sale in 97 markets as of June 30, 2025, and were used by over 41 million legal-age consumers worldwide. The smoke-free business accounted for 41% of the company’s total net revenues in the first half of 2025.
The company’s current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn devices, nicotine pouches, and e-vapor products.
The dividend announcement was made in a company press release.
In other recent news, Philip Morris International Inc. reported its second-quarter earnings for 2025, with an adjusted diluted earnings per share (EPS) of $1.91, exceeding the forecasted $1.86. However, the company’s revenue of $10.14 billion did not meet expectations, falling short of the anticipated $10.31 billion. This revenue shortfall resulted in a 1.65% revenue surprise. Additionally, UBS has adjusted its price target for Philip Morris to $166 from $177, maintaining a Neutral rating. This revision is due to reduced forecasts for the company’s ZYN nicotine pouches. UBS has lowered its fiscal year 2025/2026 estimates for US ZYN cans to 801/922 million from 826/1,033 million previously. Revenue projections for ZYN have also been cut to $2.52/2.76 billion from $2.66/3.48 billion. These developments reflect ongoing adjustments in the company’s performance and market expectations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.